Welcome To www.LupusMCTD.com
December 08, 2024, 10:15:32 am *
Welcome, Guest. Please login or register.

Login with username, password and session length
 
   Home   Forum Help Search Calendar Login Register  
Pages: 1   Go Down
  Print  
Author Topic: New Indication Approved for Lyrica Capsules/peripheral neuropathic pain.  (Read 3286 times)
0 Members and 1 Guest are viewing this topic.
Adminஐﻬ
"Pay It Forward" ஐﻬ
Site Owner
******
Offline Offline

Gender: Female
Posts: 10407


LupusMCTD Founder ஐﻬ


WWW
« on: October 28, 2010, 09:22:49 am »

New Indication Approved for Lyrica Capsules

October 27, 2010, Pfizer Japan Inc. (Head Office: Tokyo; President: Ichiro Umeda; hereinafter “Pfizer”) received approval to replace the indication of “postherpetic neuralgia” that is currently approved for Lyrica® Capsules (generic name: pregabalin; hereinafter “Lyrica®”) in Japan with the new and broader indication of “peripheral neuropathic pain.”

Approval to produce and distribute Lyrica® with the indication postherpetic neuralgia was received on April 16 of this year, and it was launched on June 22. Pfizer and Eisai Co., Ltd. (Head Office: Tokyo; President: Haruo Naito) are jointly promoting the drug in Japan and providing information regarding the proper usage of the drug.

Lyrica® is a therapeutic agent for the treatment of pain developed by Pfizer Inc. (USA). It has been approved in 110 countries and regions worldwide (as of July 2010). The drug is recommended by the International Association for the Study of Pain and other key academic bodies as a first-line treatment for neuropathic pain. As its major mechanism of action, Lyrica® is thought to express its analgesic effect by inhibiting the release of various neurotransmitters in an overexcited nervous system.

The pathologies and pathogeneses of neuropathic pain are complex and varied, so it is considered to be a form of intractable pain for which NSAIDs (non-steroidal anti-inflammatory drugs) and other analgesics cannot be expected to have much effect.
Lyrica® has a mechanism of action that differs from those of conventional analgesic agents, so it is a new option for the treatment of pain. Its efficacy and safety have been confirmed in domestic Phase III trials and domestic long-term administration trials regarding pain accompanying diabetic neuropathy in addition to postherpetic neuralgia, a typical peripheral neuropathic disease for which it was already approved.


Pfizer Japan Inc. and Eisai Co., Ltd. will use the newly approved indication of peripheral neuropathic pain for Lyrica® to help improve the quality of life of patients suffering from pain accompanying various types of neuropathic disorders.
 

 
Logged


I look normal, as I have an "Invisible Illness". You can not catch it, you can not see it. It's called Lupus.My body is attacking itself on the inside.
www.LupusMCTD.com Represents:
1) We are patients helping researchers build a future for the lives of others...
2) Where HOPE is a WORK In Progress
3) Pay It Forward~Giving Back To The Future Lupus/MCTD Patients
Pages: 1   Go Up
  Print  
 
Jump to:  


© Page Contents, Layout, Graphics and Design All Copyrighted by Credited Artists and are Not Public Domain.



LupusMCTD Founder & Patient
Former Domestic Violence SURVIVOR
Kathy A. Patterson

Author of the Upcoming Memoir Book:
"Fighting From The Inside Out"..
A lupus patient fights the beast within her immune system and the beast at home....

e-Booklet filled with photos and videos of what abuse was, signs to look for,
where to turn to for help, and much more to help others like me...


For more information
Call the National Domestic Violence Hotline at 1−800−799−SAFE(7233)



"The Meaning of the Words in the Second Amendment .... "That the people have a right to freedom of speech, and of writing, and publishing their sentiments;"

PRIVACY NOTICE: Warning--any person and/or institution and/or Agent and/or Agency of any governmental structure including but not limited to the United States Federal Government also using or monitoring/using this website or any of its associated websites, you do NOT have my permission to utilize any of my profile information nor any of the content contained herein including, but not limited to my photos, and/ or the comments made about my photo's or any other "picture" art posted on my profile. You are hereby notified that you are strictly prohibited from disclosing, copying, distributing, disseminating, or taking any other action against me with regard to this profile and the contents herein. The foregoing prohibitions also apply to your employee(s), agent(s), student(s) or any personnel under your direction or control. The contents of this profile are private and legally privileged and confidential information, and the violation of my personal privacy is punishable by law
Photobucket
© 2008 LupusMCTD Foundation of America - All Rights Reserved
Est.November 11, 2005
"We Understand What You Are Going Through"™
Powered by EzPortal

Powered by MySQL Powered by PHP Powered by SMF 1.1.21 | SMF © 2015, Simple Machines
Twitter Mod created by 2by2host.com - a web hosting company